Details of the Drug Formulations

General Information of Drug (ID: DMCHV4I)

• Drug Name: Rifapentine Drug Info
• Synonyms: RIFAPENTINE; Rifapentina; Rifapentinum; Cyclopentylrifampicin; Rifamycin AF/ACPP; Antibiotic DL 473IT; KTC 1; 61379-65-5; MDL 473; DRG-0283; DL 473; R-773; R 77-3; 3-(N-(4-Cyclopentyl-1-piperazinyl)formimidoyl)rifamycin; 3-(4-Cyclopentyl-1-piperazinyl)iminomethylrifamycin SV; 3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)rifamycin; Rifapentin,(S); NCGC00167431-01; ZINC169621228; NCGC00167431-03; AN-15578; RPE

Indication

Disease Entry	ICD 11	Status	REF
Pulmonary tuberculosis	1B10.Z	Approved	[1]
Tuberculosis	1B10-1B1Z	Approved	[2]
Macular degeneration	9B78.3	Investigative	[3]

• Therapeutic Class: Antituberculosis Agents
• Cross-matching ID:
  PubChem CID: 135403821
  ChEBI ID: CHEBI:45304
  CAS Number: 61379-65-5
  TTD ID: D0G9IU
  INTEDE ID: DR1421
  ACDINA ID: D00592

Full List of Drug Formulations Containing This Drug

Rifapentine 150 mg tablet

Company	Formulation ID	FDA Description
Sanofi-Aventis	F18989	Sodium lauryl sulfate; Calcium stearate; Fd&c blue no. 2; Sodium ascorbate; Edetate disodium; Ferric oxide red; Propylene glycol; Titanium dioxide; Aluminum oxide; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Microcrystalline cellulose; Polyethylene glycol, unspecified; Sodium starch glycolate type a corn; Starch, corn
Sanofi-Aventis	F18990	Sodium lauryl sulfate; Calcium stearate; Fd&c blue no. 2; Sodium ascorbate; Ferric oxide red; Propylene glycol; Titanium dioxide; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols

References

• [1] Rifapentine FDA Label
• [2] Novel agents in the management of Mycobacterium tuberculosis disease. Curr Med Chem. 2007;14(18):2000-8.
• [3] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.